Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | AKT1 | P31749 | 7/20 | 0.48 |
| ▸ | AKT2 | P31751 | 3/20 | 0.48 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | ESR1 | P03372 | 1/20 | 0.45 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.45 |
| ▸ | AKT3 | Q9Y243 | 1/20 | 0.44 |
| ▸ | PRKACA | P17612 | 1/20 | 0.44 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.44 |
| ▸ | GSK3B | P49841 | 1/20 | 0.44 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.44 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.43 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.43 |
| ▸ | GSR | P00390 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13023888 | 1.00 | MAPK1 (0.51) | MAPK1HTTAKT1AKT2RECQL | |
| SCHEMBL804898 | 0.93 | AKT1 (0.53) | MAPK1HTTAKT1AKT2AKT3 | |
| SCHEMBL13052984 | 0.90 | AKT1 (0.53) | MAPK1HTTAKT1AKT2AKT3 | |
| SCHEMBL804817 | 0.87 | MAPK1 (0.66) | MAPK1HTTRECQLESR1ESR2 | |
| SCHEMBL15437481 | 0.86 | ESR1 (0.57) | MAPK1HTTAKT1AKT2RECQL | |
| SCHEMBL15197419 | 0.85 | ESR1 (0.52) | MAPK1HTTAKT1AKT2RECQL | |
| SCHEMBL13023868 | 0.85 | ESR1 (0.52) | MAPK1HTTAKT1AKT2RECQL | |
| SCHEMBL18082487 | 0.85 | ESR1 (0.56) | MAPK1HTTAKT1AKT2RECQL | |
| SCHEMBL13943559 | 0.84 | RECQL (0.52) | MAPK1HTTAKT1AKT2RECQL | |
| SCHEMBL13052950 | 0.82 | AKT1 (0.59) | AKT1AKT2AKT3MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11171293-B2 | Organic electroluminescent element, material for organic electroluminescent element, light emitting device, display device and lighting device each using said element, and compound used for said element | UDC IRELAND LIMITED (IE) | 2021-11-09 | — | — | US | disclosed |
| US-20140319507-A1 | Organic Electroluminescent Element, Material for Organic Electroluminescent Element, Light Emitting Device, Display Device and Lighting Device Each Using Said Element, and Compound Used for Said Element | UDC IRELAND LIMITED (IE) | 2014-10-30 | — | — | US | disclosed |
| US-20140319507-A1 | Organic Electroluminescent Element, Material for Organic Electroluminescent Element, Light Emitting Device, Display Device and Lighting Device Each Using Said Element, and Compound Used for Said Element | UDC IRELAND LIMITED (IE) | 2014-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11171293-B2 | Organic electroluminescent element, material for organic electroluminescent element, light emitting device, display device and lighting device each using said element, and compound used for said element | L1CAM, OR10J3, INTS9 | MAPK1 1514/4885HTT 4282/4885AKT1 1686/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.